Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver transplantation--development and experiences].

O Søreide1, B Husberg, K Bjøro

  • 1Kirurgisk avdeling, Rikshospitalet, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|October 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.

Clinical and experimental immunology·2020
Same author

Natural killer T cells mediate inflammation in the bile ducts.

Mucosal immunology·2018
Same author

Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease.

Scandinavian journal of gastroenterology·2017
Same author

Peptidergic innervation of the internal anal sphincter in Hirschsprung's disease.

Pediatric surgery international·2013
Same author

Production of a Standardized Anti-Lymphocyte Globulin.

Behring Institute Mitteilungen·2010
Same author

Validation of a cholangiographic prognostic model in primary sclerosing cholangitis.

Endoscopy·2010
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Norway

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Public Health

Background:

  • Norway established its liver transplant program in 1984.
  • 200 liver transplantations were performed by March 1999.
  • Comparative data from Nordic, European, and US registries are included.

Purpose of the Study:

  • To outline data for 200 consecutive liver transplant patients in Norway.
  • To analyze survival rates and compare transplantation activity with other Nordic countries.
  • To discuss future trends and advances in liver transplantation.

Main Methods:

  • Retrospective analysis of 200 consecutive liver transplant cases in Norway.
  • Inclusion of data from the Nordic Liver Transplant Registry (NLTR), European Liver Transplant Registry (ELTR), and United Network for Organ Sharing (UNOS).

Related Experiment Videos

  • Comparison of liver transplantation rates per capita among Nordic countries.

    • Main Results:

    • One-year and three-year survival rates for Norwegian patients improved significantly, reaching 85% and 75% for the 1995-98 period.
    • Norway's liver transplantation rate (3.4/million/year) was lower than Sweden (7.8), Finland (5.7), and Denmark (5.4) between 1990-98.
    • The study highlights a potentially low number of liver transplantations in Norway.

    Conclusions:

    • Liver transplant survival rates in Norway have shown marked improvement over time.
    • The lower rate of liver transplantation in Norway suggests potential underutilization of this treatment for end-stage liver disease.
    • Active participation in international registries (NLTR, ELTR) is crucial for quality control and monitoring outcomes.